Explore
Premium
Sign Up
Log In
CRT 2017 : FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
FDA Town Hall - Evaluating DES for High-Risk DAPT Patients
Featuring
Michael John
Davide Capodanno
Hans-Peter Stoll
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Adjunctive DAPT Labeling for DES – An FDA View - Michael John
Short versus Long DAPT Studies – An Academic View - Davide Capodanno
Study Designs of Short DAPT in the USA – Challenges and Execution of Pivotal Trials - Hans-Peter Stoll
Target Audience
Learning Objectives
Related Moments
CRT 2015 Valve & Structural - Mitral Stenosis, Failure and Paravalvular Leak
Conference
A session on Mitral Stenosis, Failure and Paravalvular Leak at CRT 2015
CRT 2016 Technology & Innovation - The Drug-coated Balloon Periphery
Conference
The Drug-coated Balloon Periphery at CRT 2016
The FUTURE Study
Roundtable
FUTURE is a French open label, randomized clinical trial designed to test the superiority of FFR against angiography guided revascularization. Some of the early outcomes of the study were reported...
Supported By
Loading Simple Education
